PHARMACODYNAMICS OF HIGH-DOSE VECURONIUM IN CHILDREN DURING BALANCED ANESTHESIA

被引:19
|
作者
SLOAN, MH
LERMAN, J
BISSONNETTE, B
机构
[1] UNIV TORONTO,HOSP SICK CHILDREN,DEPT ANAESTHESIA,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
关键词
ANESTHESIA; PEDIATRIC; ANESTHETIC TECHNIQUES; BALANCED; MEASUREMENT TECHNIQUES; ELECTROMYOGRAPHY; NEUROMUSCULAR RELAXANTS; SUCCINYLCHOLINE; VECURONIUM; PHARMACODYNAMICS;
D O I
10.1097/00000542-199104000-00006
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
To compare the speed of onset, intubating conditions, duration of action, and recovery from neuromuscular blockade with vecuronium to those with succinylcholine, 40 ASA physical status 1 or 2 children (ages 2-9 yr) were studied during N2O-O2-opioid anesthesia. Each child was randomly assigned to receive a bolus dose of one of the following muscle relaxants: succinylcholine 2.0 mg/kg (n = 10), vecuronium 0.1 mg/kg (n = 10), vecuronium 0.2 mg/kg (n = 10), or vecuronium 0.4 mg/kg (n = 10). The evoked electromyogram of the abductor digiti minimi to train-of-four stimulation was monitored. We found that with succinylcholine, the time to 95% twitch depression (speed of onset, mean +/- SD), 24 +/- 7 s, was significantly less than that with each dose of vecuronium: 0.1 mg/kg, 83 +/- 21 s; 0.2 mg/kg, 58 +/- 17 s; and 0.4 mg/kg, 39 +/- 11 s, respectively (P < 0.05). The time to laryngoscopy and intubation did not differ significantly between succinylcholine (48 +/- 10 s) and vecuronium 0.4 mg/kg (57 +/- 13 s); however, both were significantly less than than with vecuronium 0.1 and 0.2 mg/kg (P < 0.005). The intubating conditions were excellent in 100% of patients. The duration of action was least with succinylcholine (5.7 +/- 1.5 min) and increased with increasing doses of vecuronium: 0.1 mg/kg, 23.9 +/- 5.1 min; 0.2 mg/kg, 55.2 +/- 11.6 min; and 0.4 mg/kg, 74.6 +/- 9.9 min, respectively (P < 0.001). The recovery index was most rapid with succinylcholine (1.6 +/- 0.4 min) and was slowest with vecuronium 0.4 mg/kg (22.6 +/- 2.1 min) (P < 0.005). In conclusion, vecuronium 0.4 mg/kg reliably depresses the twitch response to 5% of control within 60 s in 95% of children. The rapid speed of onset is associated with an increased duration of action, which is less than 90 min.
引用
收藏
页码:656 / 659
页数:4
相关论文
共 50 条
  • [21] HIGH-DOSE FLUNITRAZEPAM ANESTHESIA
    ELDOR, J
    MEDICAL HYPOTHESES, 1992, 38 (04) : 352 - 354
  • [22] ANESTHESIA FOR HIGH-DOSE TOTAL-BODY IRRADIATION IN CHILDREN
    LO, JN
    BUCKLEY, JJ
    KIM, TH
    LOPEZ, R
    ANESTHESIOLOGY, 1984, 61 (01) : 101 - 103
  • [23] HIGH-DOSE NARCOTIC ANESTHESIA
    STANLEY, TH
    SEMINARS IN ANESTHESIA PERIOPERATIVE MEDICINE AND PAIN, 1982, 1 (01): : 21 - 32
  • [24] ABSENCE OF SEIZURES DURING INDUCTION OF ANESTHESIA WITH HIGH-DOSE FENTANYL
    MURKIN, JM
    MOLDENHAUER, CC
    HUG, CC
    EPSTEIN, CM
    ANESTHESIA AND ANALGESIA, 1984, 63 (05): : 489 - 494
  • [25] PLASMA PROLACTIN CONCENTRATIONS DURING HIGH-DOSE OPIOID ANESTHESIA
    HYNYNEN, M
    LEHTINEN, AM
    SALMENPERA, M
    HEINONEN, J
    BRITISH JOURNAL OF ANAESTHESIA, 1988, 60 (02) : 245 - 246
  • [26] SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF HIGH-DOSE ETOPOSIDE
    SCHWINGHAMMER, TL
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) : 2768 - 2768
  • [27] PHARMACOKINETICS AND PHARMACODYNAMICS OF HIGH-DOSE GLUCOCORTICOID ESTERS
    DERENDORF, H
    MOLLMANN, H
    ROHDEWALD, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 198 - 198
  • [28] Pharmacodynamics of high-dose methotrexate in pediatric patients
    Aquerreta, I
    Aldaz, A
    Giráldez, J
    Sierrasesúmaga, L
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (09) : 1344 - 1350
  • [29] Vecuronium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children
    Davinia Withington
    Guillaume Menard
    Jennifer Harris
    Pradeep Kulkarni
    François Donati
    France Varin
    Canadian Journal of Anesthesia, 2000, 47 : 1188 - 1195
  • [30] Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumors
    Bouligand, J.
    Le Maitre, A.
    Valteau-Couanet, D.
    Grill, J.
    Drouard-Troalen, L.
    Paci, A.
    Hartmann, O.
    Benhamou, E.
    Vassal, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (04) : 402 - 409